Overview

Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)

Status:
Completed

Trial end date:
2023-10-30

Target enrollment:

Participant gender:

Summary

The goal of this study is to analyze in treatment-naïve HIV patients the antiviral activity, using a test and treat strategy, in real life of BIC/FTC/TAF. Secondary, this study aims to evaluate outcomes for implementation of the evidence based test and treat strategy.

Phase:

Phase 4

Details

Lead Sponsor:

Carmen Hidalgo Tenorio

Collaborator:

Gilead Sciences